A new kaurane diterpenoid from Isodon inflexus.

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Immunology

Background:

• Isodon inflexus is a plant source of bioactive compounds.
• Nuclear transcription factor-kappa B (NF-κB) plays a crucial role in inflammatory responses.
• Inhibiting NF-κB activation is a therapeutic strategy for inflammatory diseases.

Purpose of the Study:

• To isolate and characterize compounds from Isodon inflexus.
• To evaluate the inhibitory effects of these compounds on TNF-α-induced NF-κB activation.

Main Methods:

• Phytochemical investigation of Isodon inflexus aerial parts.
• Isolation guided by a nuclear transcription factor-kappa B (NF-κB)-dependent reporter gene assay.
• Structure elucidation using extensive spectroscopic analysis (UV, IR, MS, 1D- and 2D-NMR).
• In vitro evaluation of NF-κB inhibitory activity.

Main Results:

• A new 7,20-epoxy kaurane diterpenoid, 15-acetyldemethylkamebacetal A (1), was identified.
• Six known kaurane diterpenoids (2-7) were also isolated.
• All seven isolated compounds demonstrated inhibitory activity against TNF-α-induced NF-κB activation.
• The IC50 values for NF-κB inhibition ranged from 1.91 to 20.15 μM.

Conclusions:

• Isodon inflexus contains compounds with significant NF-κB inhibitory potential.
• 15-acetyldemethylkamebacetal A is a novel kaurane diterpenoid with NF-κB inhibitory activity.
• These findings suggest potential therapeutic applications for Isodon inflexus-derived compounds in inflammatory conditions.